发明名称 THERAPEUTIC OR PREVENTIVE AGENT FOR MEIBOMIAN GLAND DYSFUNCTION OR MEIBOMIAN GLAND BLOCKAGE
摘要 The objective of the present invention is to provide a new medicinal use of clarithromycin. The present invention is a therapeutic agent or a preventive agent for meibomian gland dysfunction or meibomian gland blockage and comprises clarithromycin as an active ingredient. The dosage form is preferably an eye drop or eye ointment.
申请公布号 US2017071852(A1) 申请公布日期 2017.03.16
申请号 US201615363583 申请日期 2016.11.29
申请人 Santen Pharmaceutical Co., Ltd. 发明人 KIDO Kazutaka;NAGANO Takashi
分类号 A61K9/00;A61K31/7048 主分类号 A61K9/00
代理机构 代理人
主权项 1. A method for therapy of meibomian gland dysfunction that is a condition where a diffuse abnormality of the function of the meibomian glands is induced by various causes, the method comprising administration of clarithromycin to a subject in need thereof.
地址 Osaka JP